Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
IBUPROFEN REQUIRED NDA FOR OTC MARKETING BECAUSE IT IS NEW, 200 MG DOSE, FDA TELLS CHATTEM IN MAY 18 REJECTION OF CITIZEN PETITION; POLICY DEFENDED
May 21 1984
•
By
The Pink Sheet
More from Archive
More from Pink Sheet